Lyra Therapeutics logo

Lyra Therapeutics share price today

(LYRA)

Lyra Therapeutics share price is $0.22 & ₹18.88 as on 7 Jan 2025, 2.30 'hrs' IST

$0.22

0.01

(6.54%)

Market is closed - opens 8 PM, 07 Jan 2025

View live Lyra Therapeutics share price in Dollar and Rupees. Guide to invest in Lyra Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Lyra Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

Lyra Therapeutics share price movements

  • Today's Low: $0.20
    Today's High: $0.22

    Day's Volatility :10.23%

  • 52 Weeks Low: $0.16
    52 Weeks High: $6.79

    52 Weeks Volatility :97.61%

Lyra Therapeutics Returns

PeriodLyra Therapeutics IncIndex (Russel 2000)
3 Months
-4.85%
0.0%
6 Months
-23.3%
0.0%
1 Year
-96.13%
0.0%
3 Years
-95.08%
-19.8%

Lyra Therapeutics Key Statistics

in dollars & INR

Previous Close
$0.208
Open
$0.2077
Today's High
$0.2209
Today's Low
$0.1983
Market Capitalization
$13.5M
Today's Volume
$3.3M
52 Week High
$6.79
52 Week Low
$0.1625
Revenue TTM
$1.5M
EBITDA
$-67.0M
Earnings Per Share (EPS)
$-1.49
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-186.18%

How to invest in Lyra Therapeutics from India?

It is very easy for Indian residents to invest directly in Lyra Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Lyra Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Lyra Therapeutics or LYRA on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Lyra Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Lyra Therapeutics shares which would translate to 3.900 fractional shares of Lyra Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Lyra Therapeutics, in just a few clicks!

Returns in Lyra Therapeutics for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Lyra Therapeutics investment value today

Current value as on today

₹7,319

Returns

₹92,681

(-92.68%)

Returns from Lyra Therapeutics Stock

₹95,903 (-95.9%)

Dollar Returns

₹3,223 (+3.22%)

Indian investors sentiment towards Lyra Therapeutics

81%

Period: Oct 8, 2024 to Jan 6, 2025. Change in 30 Days versus previous period

Search volume for Lyra Therapeutics on INDmoney from India has grown in the last 30 days as on Jan 7, 2025. 81% more investors are searching Lyra Therapeutics in the last 30 days versus the previous period.

Global Institutional Holdings in Lyra Therapeutics

  • Perceptive Advisors LLC

    19.49%

  • Citadel Advisors Llc

    7.29%

  • BlackRock Inc

    4.32%

  • Samsara BioCapital, LLC

    4.25%

  • Vanguard Group Inc

    2.72%

  • Ikarian Capital, LLC

    1.61%

Analyst Recommendation on Lyra Therapeutics

Buy

    91%Buy

    8%Hold

    0%Sell

Based on 12 Wall street analysts offering stock ratings for Lyra Therapeutics(by analysts ranked 0 to 5 stars)

Based on 12 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
11
11
11
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Lyra Therapeutics

What analysts predicted

Upside of 468.18%

Current:

$0.22

Target:

$1.25

Insights on Lyra Therapeutics

  • Price Movement

    In the last 7 days, LYRA stock has moved down by -5.5%
  • Decreasing Revenue

    Revenue is down for the last 2 quarters, 598.0K → 195.0K (in $), with an average decrease of 67.4% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, -48.13M → -11.87M (in $), with an average increase of 305.4% per quarter
  • LYRA vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 23.7% return, outperforming this stock by 119.7%
  • LYRA vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 55.2% return, outperforming this stock by 150.3%
  • Price to Sales

    ForLYRA every $1 of sales, investors are willing to pay $9.0, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.2 for every $1 of sales.

Lyra Therapeutics Technicals Summary

Sell

Neutral

Buy

Lyra Therapeutics is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Lyra Therapeutics Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Lyra Therapeutics Inc
-1.38%
-23.3%
-96.13%
-95.08%
-98.88%
Regeneron Pharmaceuticals, Inc.
-8.86%
-31.87%
-20.46%
15.59%
87.28%
Biontech Se
-4.16%
43.82%
3.49%
-49.66%
167.6%
Alnylam Pharmaceuticals, Inc.
-8.45%
-8.03%
19.03%
56.02%
98.44%
Vertex Pharmaceuticals Incorporated
-14.11%
-16.23%
-2.87%
81.78%
76.8%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Lyra Therapeutics Inc
NA
NA
NA
-1.27
-1.86
-0.42
NA
0.32
Regeneron Pharmaceuticals, Inc.
17.61
17.61
1.06
45.07
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.11
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.06
0.51
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Lyra Therapeutics Inc
Buy
$13.5M
-98.88%
NA
0.0%
Regeneron Pharmaceuticals, Inc.
Buy
$78.3B
87.28%
17.61
33.61%
Biontech Se
Buy
$27.3B
167.6%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$30.4B
98.44%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$103.7B
76.8%
32.84
-4.51%

About Lyra Therapeutics

lyra therapeutics, inc., a clinical-stage therapeutics company, focuses on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. the company's xtreo technology platform is designed to deliver medicines directly to the affected tissue for sustained periods with a single administration. its product candidates include lyr-210 and lyr-220, which are bioresorbable polymeric matrices for the treatment of chronic rhinosinusitis. the company was formerly known as 480 biomedical, inc. and changed its name to lyra therapeutics, inc. in july 2018. lyra therapeutics, inc. was founded in 2005 and is headquartered in watertown, massachusetts.
Organization
Lyra Therapeutics
Employees
88
CEO
Dr. Harlan W. Waksal M.D.
Industry
Health Technology

Management People of Lyra Therapeutics

NameTitle
Dr. Harlan W. Waksal M.D.
Executive Chairman
Dr. Maria Palasis Ph.D.
CEO, President & Director
Dr. Carmichael S. Roberts Jr., Ph.D.
Co-Founder
Mr. Jason Cavalier
CFO, Treasurer & Secretary
Mr. Ray Knox
Vice President of Operations
Mr. Ronan P. O'Brien J.D.
Chief Legal Officer
Ms. Vineeta Belanger Ph.D.
Senior Vice President of Clinical Affairs
Dr. Robert Richard Ph.D.
Senior Vice President of Technical Operations
Dr. Robert Kern M.D.
Chief Clinical Advisor
Ms. Gloria Cosgrove
Senior Vice President of Quality

Important FAQs about investing in Lyra Therapeutics from India :

What is Lyra Therapeutics share price today?

Lyra Therapeutics share price today stands at $0.22, Open: $0.21 ; Previous Close: $0.21 ; High: $0.22 ; Low: $0.20 ; 52 Week High: $6.79 ; 52 Week Low: $0.16. The stock opens at $0.21, after a previous close of $0.21. The stock reached a daily high of $0.22 and a low of $0.20, with a 52-week high of $6.79 and a 52-week low of $0.16.

Can Indians buy Lyra Therapeutics shares?

Yes, Indians can invest in the Lyra Therapeutics (LYRA) from India.

With INDmoney, you can buy Lyra Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Lyra Therapeutics at zero transaction cost.

How can I buy Lyra Therapeutics shares from India?

It is very easy to buy Lyra Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Lyra Therapeutics be purchased?

Yes, you can buy fractional shares of Lyra Therapeutics with INDmoney app.

What are the documents required to start investing in Lyra Therapeutics stocks?

To start investing in Lyra Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Lyra Therapeutics

Today’s highest price of Lyra Therapeutics (LYRA) is $0.22.

Today’s lowest price of Lyra Therapeutics (LYRA) is $0.20.

What is today's market capitalisation of Lyra Therapeutics

Today's market capitalisation of Lyra Therapeutics LYRA is 13.5M

What is the 52 Week High and Low Range of Lyra Therapeutics

  • 52 Week High

    $6.79

  • 52 Week Low

    $0.16

What are the historical returns of Lyra Therapeutics?

  • 1 Month Returns

    -1.38%

  • 3 Months Returns

    -23.3%

  • 1 Year Returns

    -96.13%

  • 5 Years Returns

    -98.88%

Who is the Chief Executive Officer (CEO) of Lyra Therapeutics

Dr. Harlan W. Waksal M.D. is the current Chief Executive Officer (CEO) of Lyra Therapeutics.